Engineers Gate Manager
FBIO icon

Engineers Gate Manager’s Fortress Biotech FBIO Stock Holding History

Engineers Gate Manager’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,298
Closed -$16K – 1756
2022
Q2 		$16K Buy
+1,298
New +$19.2K ﹤0.01% 1829

Other funds holding FBIO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Engineers Gate Manager's FBIO Position: Q3 2022 in Review

Engineers Gate Manager sold out of Fortress Biotech (FBIO) in Q3 2022, closing a stake of 1,298 shares — an estimated $16K sold.

Engineers Gate Manager first reported a position in FBIO in Q2 2022 and held it in 1 quarter. The position peaked at $16K in Q2 2022. 64 funds tracked by Wall St. Rank hold FBIO as of Q3 2022.

  • Engineers Gate Manager reported no remaining Fortress Biotech position as of Q3 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 1,298 Fortress Biotech shares in Q3 2022, an estimated $16K.
  • Engineers Gate Manager first reported a position in Fortress Biotech in Q2 2022 and held it in 1 quarter.
  • Engineers Gate Manager's Fortress Biotech position peaked at $16K in Q2 2022.
  • 64 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2022.

Based on Engineers Gate Manager's 13F filing for Q3 2022, filed 14 Nov 2022.